FDA questions safety of experimental diabetes drug (AP)
AP – Federal health regulators have concerns about bladder and breast cancer seen in patients taking an experimental diabetes pill from Bristol-Myers Squibb and AstraZeneca.
View full post on Yahoo! News: Health News
Leave a Reply